![]() ![]() Most people in LA drive and drive and drive … and sit in lots of traffic. Walking is not exactly what comes to mind when you think of LA. A few months ago, I took a five-hour walking food tour of several LA neighborhoods. There are more than 4,000 taco trucks and close to 25,000 restaurants in LA County that represent cultures and cuisine from all over the world. ![]() Los Angeles is one of the most exciting, diverse food cities in the country. The company earlier on Monday announced a partnership with Ionis Pharmaceuticals Inc (IONS.O) to develop and commercialize a therapy for antisense oligonucleotide (ASO), a rare, severe chronic kidney disease.Mochi in many flavors from Fugetsu-Do (Kathy Gunst/Here & Now) There was no immediate comment from Seattle-based Chinook. The firm has a "buy" recommendation and a price target of $51 on the stock. Previously, Bloom Burton had said previously there was a 70% probability the FDA approves Chinook's atrasentan. Antonia Borovina, an analyst at Bloom Burton Securities in Toronto, declined to comment as she had not yet fully read the Muddy Waters report. There are six analysts with "buy" recommendations for Chinook, according to Refinitiv data. Muddy Waters said Chinook's drug atrasentan has been shown to be harmful to patients’ cardiovascular health and that is was not producing the desired effect on chronic kidney disease. ![]() But immediately after Muddy Waters announced its short position, a bet the stock would decline, Chinook shares fell as low as $19.20, down 18% from the $23.40 close on Monday. The stock was last down 6.77% at $21.815 a share. LONDON, May 16 (Reuters) - Shares of Chinook Therapeutics Inc (KDNY.O) tumbled 18% and then pared losses on Tuesday after short-seller Muddy Waters said it was "highly unlikely" that the company's treatment for chronic kidney disease would receive U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |